BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11535553)

  • 1. Second primary ovarian cancer among women diagnosed previously with cancer.
    Hall HI; Jamison P; Weir HK
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):995-9. PubMed ID: 11535553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second malignant neoplasms among long-term survivors of ovarian cancer.
    Travis LB; Curtis RE; Boice JD; Platz CE; Hankey BF; Fraumeni JF
    Cancer Res; 1996 Apr; 56(7):1564-70. PubMed ID: 8603403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of women with metachronous breast and ovarian carcinomas.
    Liou WS; Hamilton CA; Cheung MK; Osann K; Longacre TA; Teng NN; Husain A; Dirbas FM; Chan JK
    Gynecol Oncol; 2006 Oct; 103(1):190-4. PubMed ID: 16569424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
    Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second neoplasms after invasive and borderline ovarian cancer.
    Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
    Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of second primary malignancies in women with papillary thyroid cancer.
    Canchola AJ; Horn-Ross PL; Purdie DM
    Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
    McCredie M; Macfarlane GJ; Bell J; Coates M
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975-2001.
    Ahmed F; Goodman MT; Kosary C; Ruiz B; Wu XC; Chen VW; Correa CN
    Cancer; 2006 Sep; 107(5 Suppl):1162-71. PubMed ID: 16838312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancer.
    Hunter MI; Ziogas A; Flores F; Brewster WR
    Am J Clin Oncol; 2007 Feb; 30(1):1-7. PubMed ID: 17278887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary gland cancer in the United States.
    Sun EC; Curtis R; Melbye M; Goedert JJ
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1095-100. PubMed ID: 10613342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second cancer following cancer of the female genital system in Connecticut, 1935-82.
    Curtis RE; Hoover RN; Kleinerman RA; Harvey EB
    Natl Cancer Inst Monogr; 1985 Dec; 68():113-37. PubMed ID: 4088293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.
    Lee KD; Chen SC; Chan CH; Lu CH; Chen CC; Lin JT; Chen MF; Huang SH; Yeh CM; Chen MC
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2647-55. PubMed ID: 18843006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
    Cohen RJ; Curtis RE; Inskip PD; Fraumeni JF
    Cancer; 2005 Jun; 103(11):2391-6. PubMed ID: 15852362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma.
    Zablotska LB; Neugut AI
    Cancer; 2003 Mar; 97(6):1404-11. PubMed ID: 12627503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of second cancer among patients with ovarian borderline tumors.
    Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
    Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001.
    Soerjomataram I; Louwman WJ; de Vries E; Lemmens VE; Klokman WJ; Coebergh JW
    Breast Cancer Res Treat; 2005 Sep; 93(1):91-5. PubMed ID: 16184464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
    Schoen RE; Weissfeld JL; Kuller LH
    Am J Gastroenterol; 1994 Jun; 89(6):835-42. PubMed ID: 8198091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.